The Radiosensitizing Effect of Zinc Oxide Nanoparticles in Sub-Cytotoxic Dosing Is Associated with Oxidative Stress In Vitro.
head and neck squamous cell carcinoma
irradiation
oxidative DNA damage
zinc oxide nanoparticles
Journal
Materials (Basel, Switzerland)
ISSN: 1996-1944
Titre abrégé: Materials (Basel)
Pays: Switzerland
ID NLM: 101555929
Informations de publication
Date de publication:
05 Dec 2019
05 Dec 2019
Historique:
received:
06
11
2019
revised:
28
11
2019
accepted:
03
12
2019
entrez:
11
12
2019
pubmed:
11
12
2019
medline:
11
12
2019
Statut:
epublish
Résumé
Radioresistance is an important cause of head and neck cancer therapy failure. Zinc oxide nanoparticles (ZnO-NP) mediate tumor-selective toxic effects. The aim of this study was to evaluate the potential for radiosensitization of ZnO-NP. The dose-dependent cytotoxicity of ZnO-NP
Identifiants
pubmed: 31817448
pii: ma12244062
doi: 10.3390/ma12244062
pmc: PMC6947246
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Interdisziplinäres Zentrum für Klinische Forschung, Universitätsklinikum Würzburg
ID : Z-2/78
Références
Cancers (Basel). 2017 Oct 06;9(10):null
pubmed: 28984841
Environ Mol Mutagen. 2018 Apr;59(3):247-259
pubmed: 29150876
Arterioscler Thromb Vasc Biol. 2004 Nov;24(11):2021-7
pubmed: 15319267
Nanoscale. 2015 Feb 14;7(6):2154-98
pubmed: 25580680
Cancer Nanotechnol. 2017;8(1):6
pubmed: 29104699
Cancer Res. 1993 Feb 15;53(4):733-6
pubmed: 8381327
Small. 2014 Dec 29;10(24):5106-15
pubmed: 25164061
J Oral Pathol Med. 2016 Feb;45(2):77-82
pubmed: 25952002
Environ Mol Mutagen. 2011 Aug;52(7):582-9
pubmed: 21786336
N Engl J Med. 2004 May 6;350(19):1937-44
pubmed: 15128893
Expert Opin Biol Ther. 2003 Jul;3(4):655-63
pubmed: 12831370
Nanobiomedicine (Rij). 2016 Jan 1;3:9
pubmed: 29942384
Toxicol In Vitro. 2015 Jun;29(4):813-8
pubmed: 25769976
Nanoscale. 2015 May 21;7(19):8931-8
pubmed: 25916659
Materials (Basel). 2019 Jun 05;12(11):null
pubmed: 31195623
Int J Nanomedicine. 2016 Aug 11;11:3859-74
pubmed: 27570453
Cancer. 1972 Jan;29(1):117-21
pubmed: 4332311
Int J Oncol. 2010 Dec;37(6):1583-90
pubmed: 21042728
J Biomed Nanotechnol. 2014 Aug;10(8):1501-8
pubmed: 25016650
Toxicology. 2010 Sep 10;275(1-3):65-71
pubmed: 20540983
Oncol Lett. 2016 Nov;12(5):3549-3554
pubmed: 27900035
Toxicol Sci. 2006 May;91(1):227-36
pubmed: 16495353
Biotechnol Appl Biochem. 2016 Jan-Feb;63(1):113-24
pubmed: 25581219
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
pubmed: 6606682
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
J Vis Exp. 2013 Jul 07;(77):e3779
pubmed: 23852182
Int J Cancer. 2009 Nov 1;125(9):2159-65
pubmed: 19569190
Chem Soc Rev. 2013 Feb 7;42(3):1147-235
pubmed: 23238558
J Pharmacol Exp Ther. 2019 Sep;370(3):671-681
pubmed: 31040175
Mater Sci Eng C Mater Biol Appl. 2019 Oct;103:109739
pubmed: 31349426
Carcinogenesis. 1993 Sep;14(9):1733-5
pubmed: 8403192
Cancer Med. 2015 Jul;4(7):1101-16
pubmed: 25919147
Small. 2010 Sep 6;6(17):1908-17
pubmed: 20677183
Nanotechnology. 2008 Jul 23;19(29):295103
pubmed: 18836572
Part Fibre Toxicol. 2008 Nov 06;5:14
pubmed: 18990217
Toxicol Lett. 2009 Jul 24;188(2):112-8
pubmed: 19446243
ACS Appl Mater Interfaces. 2016 Feb 10;8(5):3123-34
pubmed: 26771200
Environ Mol Mutagen. 2000;35(3):206-21
pubmed: 10737956
Toxicol Sci. 2017 Mar 1;156(1):261-274
pubmed: 28115643
N Engl J Med. 2004 May 6;350(19):1945-52
pubmed: 15128894
Toxicol In Vitro. 2011 Apr;25(3):657-63
pubmed: 21232592
Colloids Surf B Biointerfaces. 2015 May 1;129:79-86
pubmed: 25829130